13 Feb Wellness Café – Pancreatic Cancer: Striving for Survival
3800 N Port Washington Rd
Milwaukee, WI 53212
You are invited to a presentation by an expert in pancreatic cancer followed by a conversation with community members.
Pancreatic cancer is the third most common cause of cancer-related death in the US. The American Cancer Society’s estimates that about 57,600 people (30,400 men and 27,200 women) will be diagnosed with pancreatic cancer in the US in 2020; and about 47,050 people (24,640 men and 22,410 women) will die of pancreatic cancer. Pancreatic cancer accounts for about 3% of all cancers in the US and about 7% of all cancer deaths. It is slightly more common in men than in women.
The focus of this Science Café is to understand why pancreatic cancer is a disease with such poor prognosis. Discussion points will include the causes of pancreatic cancer, risk factors and prevention. The presenter will also discuss why pancreatic cancer is often diagnosed at a later stage, survival rates at various stages of the disease and what type of treatment is available. Finally, our discussion will conclude with a review of current research efforts to find effective screening tests for pancreatic cancer.
- Be part of a discussion on research related to pancreatic cancer.
- Learn about research findings and how they relate to your health.
- Find answers to questions you’ve always wanted to ask.
Dinner will be served.
Presented by CTSI in collaboration with…
About the Session Leader
Susan Tsai, MD, MHS
Associate Professor, Department of Surgical Oncology
Medical College of Wisconsin
Susan Tsai, MD, MHS, earned her medical degree from the University of Michigan Medical Center at Ann Arbor, MI. She completed her residency in General Surgery at the University of Michigan, Ann Arbor, MI and two fellowships in Surgical Oncology and Surgical Oncology Research. Dr. Tsai holds a joint appointment at Froedtert & the Medical College of WI where she is an Associate Professor of Surgery; and the Clement J. Zablocki VA hospital where she serves as the Chief of Hepatopancreaticobiliary Surgery. Her clinical expertise is in GI oncology with a focus on cancers of the gastrointestinal tract, including benign and malignant pancreatic tumors. Dr. Tsai is the Director of the MCW Surgical Oncology Biorepository and Pancreatic Cancer Clinical Database. She coordinates a high-risk pancreatic cancer screening clinic and is involved in investigator initiated clinical trials which utilize molecular profiling. Her research interests are in biomarker development for treatment monitoring.